Ajinomoto Group Ventures invests in early-stage startups across food, health, and biotechnology. Their strategy focuses on creating new value for the Ajinomoto Group by addressing global challenges like sustainable food systems, personalized nutrition, and digital health.
40% of their portfolio is in Enterprise Software. Deal activity increased 50% year-over-year (3 deals in the last 12 months). Their most common stage is series-a (60% of deals).
Portfolio
5
Fund Size
$44M
Top Stage
Series A
Last 12 Mo
3
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
5 investments
Top Co-Investors
Khosla Ventures1 shared
Scifi VC1 shared
Chan Zuckerberg Initiative1 shared
Fusion Fund1 shared
Pitango HealthTech1 shared
TechAviv1 shared
Harpoon Ventures1 shared
TDK Ventures1 shared
ICM HPQC Fund1 shared
Systemiq Capital1 shared
Capital G1 shared
Last updated: 16 April 2026